- Home
- ATAT vs BRKR Comparison
ATAT vs BRKR Comparison
Compare ATAT & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATAT | BRKR |
|---|---|---|
| Founded | 2013 | 1960 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.6B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ATAT | BRKR |
|---|---|---|
| Price | $36.40 | $36.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $49.00 | $48.92 |
| AVG Volume (30 Days) | 1.1M | ★ 2.0M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.22% | 0.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $26.22 | $6.27 |
| Revenue Next Year | $18.77 | $3.78 |
| P/E Ratio | $26.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.50 | $28.53 |
| 52 Week High | $43.17 | $56.22 |
Technical Indicators
Market Signals| Indicator | ATAT | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 48.46 | 50.38 |
| Support Level | $34.52 | $35.88 |
| Resistance Level | $37.00 | $37.32 |
| Average True Range (ATR) | 1.75 | 1.73 |
| MACD | 0.13 | 0.51 |
| Stochastic Oscillator | 43.62 | 81.03 |
Price Performance
Historical ComparisonAbout ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.